Management of Antiretrovirals in Critically Ill Patients: Great Progress But Potential Pitfalls

Crit Care Med. 2018 May;46(5):663-665. doi: 10.1097/CCM.0000000000003048.

Authors

Dante A Suffredini¹, Jomy M George, Henry Masur

Affiliation

¹ Section of Critical Care, Department of Medicine, St. Agnes Hospital, Baltimore, MD; and Department of Critical Care Medicine, Clinical Center, National Institutes of Health, Bethesda, MD Clinical Pharmacokinetics Research Unit, Department of Clinical Center Pharmacy, National Institutes of Health, Bethesda, MD Department of Critical Care Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.

No abstract available

Publication types

Letter

MeSH terms

Anti-HIV Agents / administration & dosage
Anti-HIV Agents / adverse effects
Anti-HIV Agents / therapeutic use*
Critical Illness / therapy*
Drug Interactions
Drug Resistance, Viral
HIV Infections / complications
HIV Infections / drug therapy*
Humans

Substances

Anti-HIV Agents

Grants and funding

Z01 CL001170-07/Intramural NIH HHS/United States